Author:
Yoon Sarah,Choi Ji-Hye,Kim Sung Joo,Lee Eun-Ju,Shah Masaud,Choi Sangdun,Woo Hyun Goo
Funder
Korea Health Industry Development Institute
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Subject
Clinical Biochemistry,Molecular Biology,Molecular Medicine,Biochemistry
Reference32 articles.
1. Yoon, S. et al. Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer. Oncogene 37, 4443–4454 (2018).
2. Menzel, P., Valencia, F., Godement, P., Dodelet, V. C. & Pasquale, E. B. Ephrin-A6, a new ligand for EphA receptors in the developing visual system. Dev. Biol. 230, 74–88 (2001).
3. Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee. Cell. 90, 403-404 (1997)
4. Gurniak, C. B. & Berg, L. J. A new member of the Eph family of receptors that lacks protein tyrosine kinase activity. Oncogene 13, 777–786 (1996).
5. Matsuoka, H. et al. Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem. Biophys. Res. Commun. 235, 487–492 (1997).
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献